Press & events

What's happening?

Stay updated on our latest news and events.

Displaying 1 - 10 of 170

Insights

Understanding the solution chemistry of the systems evolving from complex multidrug amorphous formulations continues to be a grand challenge in field of drug development of fixed dose combinations (FDCs). In this article, we contribute to advancing the knowledge of FDC formulations by rationalizing the solution behavior of drugs during dissolution and supersaturation.

Insights

Q1. Why is it even important for pharma to be a sustainable industry? Surely healthcare is so important to people, literally vitally so, that pharma gets a free pass when it comes to its environmental impact?

Insights

Analytical chemistry’s role in drug development is to provide assurance of the quality, safety, and efficacy of new medicines. The effectiveness with which these analytical requirements are carried out can also have a marked impact on the speed that a product is ready for market.

Insights

The most significant impact on the environment comes from commercial scale pharmaceutical manufacturing.

Insights

Many now realise the benefits that working with a contract provider with specialist expertise in analytical testing can offer in terms of accelerating timelines. 

Insights

In recent years, there has been increasing concerns around drug supply shortages and discussions around the potential benefits of relocating medicine production back to the EU.

Insights

Featured in a roundtable with On Drug Delivery, Recipharm’s Senior Director, Technology and Strategic Investments, Torkel Gren, speaks about the different dosage forms and administration routes available to drug developers, referencing some of the key trends in the sector.

Insights

In recent years there has been a change in focus for drug formulators as it becomes more critical that the needs of the patient are considered when developing new drug products. The focus on the overall patient experience is a priority now, particularly as specific dosage forms can have a different impact on the user and their ability to take medications effectively or correctly. 

Insights

The outbreak of COVID-19 has had a mixture of effects on the injection delivery market. For example, some patients have delayed their care for fear of going into healthcare settings for treatment and potentially contracting the disease. 

Insights

Companies working in the drug development space are under increasing pressure to provide more innovative solutions for medications. Working with an end-to-end CDMO can help to reduce complexity and timelines, and ultimately ensure smoother progress to market.